Genetic variants associated with susceptibility to idiopathic pulmonary fibrosis in people of European ancestry: a genome-wide association study

The Lancet Respiratory Medicine

Volumn 5, Issue 11, 2017, Pages 869-880

  Allen, Richard J ^a   Porte, Joanne ^b,c   Braybrooke, Rebecca ^b,c   Flores, Carlos ^d,e,f   Fingerlin, Tasha E ^g,h   Oldham, Justin M ⁱ   Guillen Guio, Beatriz ^d   Ma, Shwu Fan ^j   Okamoto, Tsukasa ^h   John, Alison E ^b,c   Obeidat, Ma'en ^k   Yang, Ivana V ^g,h   Henry, Amanda ^b,c   Hubbard, Richard B ^b,c   Navaratnam, Vidya ^b,c   Saini, Gauri ^b,c   Thompson, Norma ^b,c   Booth, Helen L ^l   Hart, Simon P ^m   Hill, Mike R ⁿ   Hirani, Nik ^o   Maher, Toby M ^p,q   McAnulty, Robin J ^r   Millar, Ann B ^s   Molyneaux, Philip L ^p,q   Parfrey, Helen ^t   Rassl, Doris M ^t   Whyte, Moira K B ^o   Fahy, William A ^u   Marshall, Richard P ^u   Oballa, Eunice ^u   Bossé, Yohan ^v   Nickle, David C ^w   Sin, Don D ^k,x   Timens, Wim ^y   Shrine, Nick ^a   Sayers, Ian ^b,c   Hall, Ian P ^b,c   Noth, Imre ^j   Schwartz, David A ^g,h   Tobin, Martin D ^a,z   Wain, Louise V ^a,z   Jenkins, R Gisli ^b,c   more..

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^c NIHR NOTTINGHAM BIOMEDICAL RESEARCH CENTRE   (United Kingdom)

^d HOSPITAL UNIVERSITARIO NUESTRA SEÑORA DE CANDELARIA   (Spain)

^e INSTITUTO DE SALUD CARLOS III   (Spain)

^f Instituto Tecnologico y de Enegias Renovables   (Spain)

^g DEPARTMENT OF MEDICINE   (United States)

^h UNIVERSITY OF COLORADO   (United States)

ⁱ UNIVERSITY OF CALIFORNIA   (United States)

^j UNIVERSITY OF CHICAGO   (United States)

^k The James Hogg iCAPTURE Centre for Cardiovascular and Pulmonary Research   (Canada)

^l UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^m UNIVERSITY OF HULL   (United Kingdom)

ⁿ UNIVERSITY OF OXFORD   (United Kingdom)

^o UNIVERSITY OF EDINBURGH   (United Kingdom)

^p ROYAL BROMPTON HOSPITAL   (United Kingdom)

^q NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^r UNIVERSITY COLLEGE LONDON   (United Kingdom)

^s UNIVERSITY OF BRISTOL   (United Kingdom)

^t PAPWORTH HOSPITAL   (United Kingdom)

^u GLAXOSMITHKLINE   (United Kingdom)

^v LAVAL UNIVERSITY   (Canada)

^w MERCK RESEARCH LABORATORIES   (United States)

^x UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^y UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^z GLENFIELD HOSPITAL   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

A KINASE ANCHORING PROTEIN 13; CYCLIC AMP DEPENDENT PROTEIN KINASE ANCHORING PROTEIN; DESMOPLAKIN; MESSENGER RNA; MUCIN 5B; UNCLASSIFIED DRUG; AKAP13 PROTEIN, HUMAN; MINOR HISTOCOMPATIBILITY ANTIGEN; ONCOPROTEIN; RHO GUANINE NUCLEOTIDE EXCHANGE FACTOR; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; RHOA PROTEIN, HUMAN;

ADULT; AGE; AGED; AKAP13 GENE; ARTICLE; CASE CONTROL STUDY; CAUCASIAN; CONTROLLED STUDY; DSP GENE; FEMALE; FIBROSING ALVEOLITIS; FOLLOW UP; GENE; GENE EXPRESSION; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOME-WIDE ASSOCIATION STUDY; GENOMICS; HUMAN; HUMAN TISSUE; LUNG ALVEOLUS EPITHELIUM; LUNG PARENCHYMA; LYMPH FOLLICLE; MAJOR CLINICAL STUDY; MALE; MUC5B GENE; PATHOGENESIS; PRIORITY JOURNAL; SEX; SMOKING; TRANSCRIPTOMICS; EUROPE; GENETIC PREDISPOSITION; GENETIC VARIATION; GENETICS; LUNG ALVEOLUS EPITHELIUM CELL; METABOLISM; MIDDLE AGED; PHYSIOLOGY; SIGNAL TRANSDUCTION; TERTIARY LYMPHOID STRUCTURE;

A KINASE ANCHOR PROTEINS; AGED; ALVEOLAR EPITHELIAL CELLS; CASE-CONTROL STUDIES; EUROPE; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOME-WIDE ASSOCIATION STUDY; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; MALE; MIDDLE AGED; MINOR HISTOCOMPATIBILITY ANTIGENS; PROTO-ONCOGENE PROTEINS; RHO GUANINE NUCLEOTIDE EXCHANGE FACTORS; RHOA GTP-BINDING PROTEIN; RNA, MESSENGER; SIGNAL TRANSDUCTION; TERTIARY LYMPHOID STRUCTURES;

EID: 85033546522     PISSN: 22132600     EISSN: 22132619     Source Type: Journal    
DOI: 10.1016/S2213-2600(17)30387-9     Document Type: Article

References (55)

1. Navaratnam, V, Fleming, KM, West, J, et al. The rising incidence of idiopathic pulmonary fibrosis in the UK. Thorax 66 (2011), 462–467.
2. Coward, WR, Saini, G, Jenkins, G, The pathogenesis of idiopathic pulmonary fibrosis. Ther Adv Respir Dis 4 (2010), 367–388.
3. Ley, B, Collard, HR, King, TE Jr, Clinical course and prediction of survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 183 (2011), 431–440.
4. King, TE Jr, Bradford, WZ, Castro-Bernardini, S, et al. A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis. N Engl J Med 370 (2014), 2083–2092.
5. Richeldi, L, du Bois, RM, Raghu, G, et al. Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis. N Engl J Med 370 (2014), 2071–2082.
6. Thomas, AQ, Lane, K, Phillips, J 3rd, et al. Heterozygosity for a surfactant protein C gene mutation associated with usual interstitial pneumonitis and cellular nonspecific interstitial pneumonitis in one kindred. Am J Respir Crit Care Med 165 (2002), 1322–1328.
7. van Moorsel, CH, van Oosterhout, MF, Barlo, NP, et al. Surfactant protein C mutations are the basis of a significant portion of adult familial pulmonary fibrosis in a Dutch cohort. Am J Respir Crit Care Med 182 (2010), 1419–1425.
8. Stuart, BD, Choi, J, Zaidi, S, et al. Exome sequencing links mutations in PARN and RTEL1 with familial pulmonary fibrosis and telomere shortening. Nat Genet 47 (2015), 512–517.
9. Mushiroda, T, Wattanapokayakit, S, Takahashi, A, et al. A genome-wide association study identifies an association of a common variant in TERT with susceptibility to idiopathic pulmonary fibrosis. J Med Genet 45 (2008), 654–656.
10. Noth, I, Zhang, Y, Ma, SF, et al. Genetic variants associated with idiopathic pulmonary fibrosis susceptibility and mortality: a genome-wide association study. Lancet Respir Med 1 (2013), 309–317.
11. Fingerlin, TE, Murphy, E, Zhang, W, et al. Genome-wide association study identifies multiple susceptibility loci for pulmonary fibrosis. Nat Genet 45 (2013), 613–620.
12. Fingerlin, TE, Zhang, W, Yang, IV, et al. Genome-wide imputation study identifies novel HLA locus for pulmonary fibrosis and potential role for auto-immunity in fibrotic idiopathic interstitial pneumonia. BMC Genet, 17, 2016, 74.
13. Mathai, SK, Newton, CA, Schwartz, DA, Garcia, CK, Pulmonary fibrosis in the era of stratified medicine. Thorax 71 (2016), 1154–1160.
14. Stuart, BD, Lee, JS, Kozlitina, J, et al. Effect of telomere length on survival in patients with idiopathic pulmonary fibrosis: an observational cohort study with independent validation. Lancet Respir Med 2 (2014), 557–565.
15. Peljto, AL, Zhang, Y, Fingerlin, TE, et al. Association between the MUC5B promoter polymorphism and survival in patients with idiopathic pulmonary fibrosis. JAMA 309 (2013), 2232–2239.
16. Nelson, MR, Tipney, H, Painter, JL, et al. The support of human genetic evidence for approved drug indications. Nat Genet 47 (2015), 856–860.
17. Travis, WD, King, TE, Bateman, ED, et al. American Thoracic Society/European Respiratory Society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 165 (2002), 277–304.
18. Raghu, G, Collard, HR, Egan, JJ, et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 183 (2011), 788–824.
19. Raghu, G, Rochwerg, B, Zhang, Y, et al. An official ATS/ERS/JRS/ALAT clinical practice guideline: treatment of idiopathic pulmonary fibrosis, an update of the 2011 clinical practice guideline. Am J Respir Crit Care Med 192 (2015), e3–e19.
20. Wain, LV, Shrine, N, Miller, S, et al. Novel insights into the genetics of smoking behaviour, lung function, and chronic obstructive pulmonary disease (UK BiLEVE): a genetic association study in UK Biobank. Lancet Respir Med 3 (2015), 769–781.
21. Marchini, J, Howie, B, Myers, S, McVean, G, Donnelly, P, A new multipoint method for genome-wide association studies by imputation of genotypes. Nat Genet 39 (2007), 906–913.
22. Kang, H, Efficient and parallelisable association container toolbox (EPACTS). http://genome.Sph.umich.edu/wiki/EPACTS, 2014 (accessed April 22, 2016).
23. McCarthy, S, Das, S, Kretzschmar, W, et al. A reference panel of 64,976 haplotypes for genotype imputation. Nat Genet 48 (2016), 1279–1283.
24. Mayers, CM, Wadell, J, McLean, K, et al. The rho guanine nucleotide exchange factor AKAP13 (BRX) is essential for cardiac development in mice. J Biol Chem 285 (2010), 12344–12354.
25. Cavin, S, Maric, D, Diviani, D, A-kinase anchoring protein-Lbc promotes pro-fibrotic signaling in cardiac fibroblasts. Biochim Biophys Acta 1843 (2014), 335–345.
26. del Vescovo, CD, Cotecchia, S, Diviani, D, A-kinase-anchoring protein-Lbc anchors IκB kinase β to support interleukin-6-mediated cardiomyocyte hypertrophy. Mol Cell Biol 33 (2013), 14–27.
27. Jenkins, RG, Su, X, Su, G, et al. Ligation of protease-activated receptor 1 enhances alpha(v)beta6 integrin-dependent TGF-beta activation and promotes acute lung injury. J Clin Invest 116 (2006), 1606–1614.
28. Xu, MY, Porte, J, Knox, AJ, et al. Lysophosphatidic acid induces alphavbeta6 integrin-mediated TGF-beta activation via the LPA2 receptor and the small G protein G alpha(q). Am J Pathol 174 (2009), 1264–1279.
29. Diviani, D, Soderling, J, Scott, JD, AKAP-Lbc anchors protein kinase A and nucleates Galpha 12-selective Rho-mediated stress fiber formation. J Biol Chem 276 (2001), 44247–44257.
30. Majumdar, M, Seasholtz, TM, Buckmaster, C, Toksoz, D, Brown, JH, A rho exchange factor mediates thrombin and Galpha(12)-induced cytoskeletal responses. J Biol Chem 274 (1999), 26815–26821.
31. Pi, M, Spurney, RF, Tu, Q, Hinson, T, Quarles, LD, Calcium-sensing receptor activation of rho involves filamin and rho-guanine nucleotide exchange factor. Endocrinology 143 (2002), 3830–3838.
32. Dutt, P, Kjoller, L, Giel, M, Hall, A, Toksoz, D, Activated Galphaq family members induce Rho GTPase activation and Rho-dependent actin filament assembly. FEBS Lett 531 (2002), 565–569.
33. Bear, MD, Li, M, Liu, Y, Giel-Moloney, MA, Fanburg, BL, Toksoz, D, The lbc rho guanine nucleotide exchange factor alpha-catulin axis functions in serotonin-induced vascular smooth muscle cell mitogenesis and RhoA/ROCK activation. J Biol Chem 285 (2010), 32919–32926.
34. Campbell, DA, Poulter, LW, Janossy, G, du Bois, RM, Immunohistological analysis of lung tissue from patients with cryptogenic fibrosing alveolitis suggesting local expression of immune hypersensitivity. Thorax 40 (1985), 405–411.
35. Wallace, WA, Howie, SE, Krajewski, AS, Lamb, D, The immunological architecture of B-lymphocyte aggregates in cryptogenic fibrosing alveolitis. J Pathol 178 (1996), 323–329.
36. Marchal-Somme, J, Uzunhan, Y, Marchand-Adam, S, et al. Cutting edge: nonproliferating mature immune cells form a novel type of organized lymphoid structure in idiopathic pulmonary fibrosis. J Immunol 176 (2006), 5735–5739.
37. Marchal-Sommé, J, Uzunhan, Y, Marchand-Adam, S, et al. Dendritic cells accumulate in human fibrotic interstitial lung disease. Am J Respir Crit Care Med 176 (2007), 1007–1014.
38. DePianto, DJ, Chandriani, S, Abbas, AR, et al. Heterogeneous gene expression signatures correspond to distinct lung pathologies and biomarkers of disease severity in idiopathic pulmonary fibrosis. Thorax 70 (2015), 48–56.
39. Xue, J, Kass, DJ, Bon, J, et al. Plasma B lymphocyte stimulator and B cell differentiation in idiopathic pulmonary fibrosis patients. J Immunol 191 (2013), 2089–2095.
40. Vuga, LJ, Tedrow, JR, Pandit, KV, et al. CXC motif chemokine 13 (CXCL13) is a prognostic biomarker of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 189 (2014), 966–974.
41. Kino, T, Souvatzoglou, E, Charmandari, E, et al. Rho family guanine nucleotide exchange factor brx couples extracellular signals to the glucocorticoid signaling system. J Biol Chem 281 (2006), 9118–9126.
42. Kino, T, Takatori, H, Manoli, I, et al. Brx mediates the response of lymphocytes to osmotic stress through the activation of NFAT5. Sci Signal, 2, 2009, ra5.
43. Knipe, RS, Tager, AM, Liao, JK, The Rho kinases: critical mediators of multiple profibrotic processes and rational targets for new therapies for pulmonary fibrosis. Pharmacol Rev 67 (2015), 103–117.
44. Wilborn, J, Crofford, LJ, Burdick, MD, Kunkel, SL, Strieter, RM, Peters-Golden, M, Cultured lung fibroblasts isolated from patients with idiopathic pulmonary fibrosis have a diminished capacity to synthesize prostaglandin E2 and to express cyclooxygenase-2. J Clin Invest 95 (1995), 1861–1868.
45. Keerthisingam, CB, Jenkins, RG, Harrison, NK, et al. Cyclooxygenase-2 deficiency results in a loss of the anti-proliferative response to transforming growth factor-β in human fibrotic lung fibroblasts and promotes bleomycin-induced pulmonary fibrosis in mice. Am J Pathol 158 (2001), 1411–1422.
46. Coward, WR, Feghali-Bostwick, CA, Jenkins, G, Knox, AJ, Pang, L, A central role for G9a and EZH2 in the epigenetic silencing of cyclooxygenase-2 in idiopathic pulmonary fibrosis. FASEB J 28 (2014), 3183–3196.
47. Evans, IC, Barnes, JL, Garner, IM, et al. Epigenetic regulation of cyclooxygenase-2 by methylation of c8orf4 in pulmonary fibrosis. Clin Sci 130 (2016), 575–586.
48. Taylor, CP, Traynelis, SF, Siffert, J, Pope, LE, Matsumoto, RR, Pharmacology of dextromethorphan: Relevance to dextromethorphan/quinidine (nuedexta®) clinical use. Pharmacol Ther 164 (2016), 170–182.
49. Mercer, PF, Woodcock, HV, Eley, JD, et al. Exploration of a potent PI3 kinase/mTOR inhibitor as a novel anti-fibrotic agent in IPF. Thorax 71 (2016), 701–711.
50. Zhu, QQ, Zhang, XL, Zhang, SM, et al. Association between the MUC5B promoter polymorphism rs35705950 and idiopathic pulmonary fibrosis: a meta-analysis and trial sequential analysis in caucasian and asian populations. Medicine, 94, 2015, e1901.
51. Skol, AD, Scott, LJ, Abecasis, GR, Boehnke, M, Optimal designs for two-stage genome-wide association studies. Genet Epidemiol 31 (2007), 776–788.
52. Yang, IV, Coldren, CD, Leach, SM, et al. Expression of cilium-associated genes defines novel molecular subtypes of idiopathic pulmonary fibrosis. Thorax 68 (2013), 1114–1121.
53. Hao, K, Bossé, Y, Nickle, DC, et al. Lung eQTLs to help reveal the molecular underpinnings of asthma. PLoS Genet, 8, 2012, e1003029.
54. Lamontagne, M, Couture, C, Postma, DS, et al. Refining susceptibility loci of chronic obstructive pulmonary disease with lung eqtls. PLoS One, 8, 2013, e70220.
55. Obeidat, M, Miller, S, Probert, K, et al. GSTCD and INTS12 regulation and expression in the human lung. PLoS One, 8, 2013, e74630.